2022
DOI: 10.1080/14787210.2022.2122442
|View full text |Cite
|
Sign up to set email alerts
|

Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 191 publications
0
1
0
Order By: Relevance
“…Antimicrobial resistance (AMR) poses a significant global public health challenge, jeopardizing our ability to combat bacterial infections, as evidenced by the emergence of superbugs ( Mitra et al, 2022 ). The World Health Organization is now adopting a “One Health” approach to address global AMR, emphasizing the interconnection of humans, animals, and environmental health ( McEwen and Collignon, 2018 ; Collineau et al, 2023 ).…”
Section: Introductionmentioning
confidence: 99%
“…Antimicrobial resistance (AMR) poses a significant global public health challenge, jeopardizing our ability to combat bacterial infections, as evidenced by the emergence of superbugs ( Mitra et al, 2022 ). The World Health Organization is now adopting a “One Health” approach to address global AMR, emphasizing the interconnection of humans, animals, and environmental health ( McEwen and Collignon, 2018 ; Collineau et al, 2023 ).…”
Section: Introductionmentioning
confidence: 99%
“…The global rise in antibiotic resistance is alarming, partially attributed to excessive and inappropriate antibiotic use ( Ghweil et al, 2022 ; Mitra et al, 2022 ). In this study, S. epidermidis exhibited high sensitivity to tigacycline, linezolid, vancomycin, quinupristin/dalfopristin, rifampicin, furantoin, and gentamicin.…”
Section: Discussionmentioning
confidence: 99%
“…The media showed perfect growth for cave actinobacteria. Antibiotic resistance is a serious concern in recent days, as WHO estimates that there will be no treatment options in the future if the rate of resistance among the bacteria continues to be the same [35,36]. The problem is that the rate of resistance in bacteria is much more than the discovery of novel antibiotics.…”
Section: Antimicrobial Activities Of Cave Actinobacteria Against Xdr ...mentioning
confidence: 99%